Grace joined Terremoto in 2022 with over 12 years of experience in strategic finance, transactions, and operations. She currently leads the company’s business development, fundraising, market analysis, and competitive intelligence efforts.

Before joining Terremoto, Grace worked in Corporate Development at Gilead Sciences, where she focused on expanding the company’s pipeline beyond virology. During her tenure, she led approximately $23 billion in M&A and in-licensing transactions across the oncology and inflammation therapeutic areas. Earlier at Gilead, she worked in Commercial Operations, managing revenue forecasting for Gilead’s $10+ billion U.S. HIV business unit and contributing to the successful launch of Biktarvy®.

Grace began her career in finance. Prior to Gilead, she was part of the investment team at BC Partners (€40 billion AUM private equity fund) in New York, focusing on leveraged buyouts and structured investments in the healthcare sector. She started her career as an investment banking analyst at Barclays Capital, where she worked on M&A transactions across the consumer products and consumer health sectors.

Grace holds a B.A. from Yale University and an M.B.A. from Harvard Business School.